Herb Cross insider trades
Open-market stock purchases and sales by Herb Cross, Chief Financial Officer at Jasper Therapeutics, Inc, from SEC Form 4 filings since Jan 23, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | JSPR Jasper Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- JSPR Jasper Therapeutics, Inc: other filings, last Jan 2, 2026
- APGN Apexigen, Inc: other filings, last Aug 23, 2023
- BCEL Atreca, Inc: 2 sales, last Aug 2, 2023
- ARMO ARMO BioSciences, Inc: other filings, last Jun 22, 2018
- KBIO Kalobios Pharmaceuticals Inc: other filings, last Nov 9, 2015
- AFFY Affymax Inc: 3 sales, last Jan 30, 2013
- FACT Facet Biotech Corp: other filings, last Apr 21, 2010